---
schema_version: "secwatch.filing_event.v1"
accession: "0001801170-22-000038"
form_type: "8-K"
ticker: "CLOV"
cik: "0001801170"
company_name: "CLOVER HEALTH INVESTMENTS, CORP. /DE"
filed_at: "2022-07-26T23:59:59+00:00"
generated_at: "2026-06-24T08:50:09.448414+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Clover Health appoints Dr. Carladenise Edwards to Board of Directors

## Summary
- Dr. Edwards appointed Class III director effective July 22, 2022.
- She will serve on Talent and Compensation and Nominating and Corporate Governance Committees.
- Receives pro rata director retainer for 2022 and $200K RSU award prorated through Sept 22, 2022 annual meeting.
- Edwards is EVP & Chief Strategy Officer at Henry Ford Health System with 30 years healthcare experience.

## SEC filing metadata
- accession: 0001801170-22-000038
- form_type: 8-K
- ticker: CLOV
- cik: 0001801170
- company_name: CLOVER HEALTH INVESTMENTS, CORP. /DE
- filed_at: 2022-07-26T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1801170/000180117022000038/0001801170-22-000038-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1801170/000180117022000038/clov-20220722.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001801170-22-000038
- JSON: https://secwatch.observer/filing/0001801170-22-000038.json
- Plain text: https://secwatch.observer/filing/0001801170-22-000038.txt

## Key facts
- Executive change
  Carladenise Armbrister Edwards was appointed as Class III director at CLOVER HEALTH INVESTMENTS, CORP. /DE.
  - Action: appointed
  - Role: Class III director
  source text: On July 22, 2022, the Board of Directors (the "Board") of Clover Health Investments, Corp. ("Clover" or the "Company") appointed Carladenise Armbrister Edwards, Ph.D., Executive Vice President and Chief Strategy Officer of the Henry Ford Health System, to serve as a Class III director of the Board and as a member of the Talent and Compensation Committee and the Nominating and Corporate Governance Committee of the Board.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1801170/000180117022000038/0001801170-22-000038-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.